SCHEMBL17599346

SCHEMBL17599346

CCOC(=O)c1cccc(-c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc23)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 5/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ KEAP1 Q14145 3/20 0.44
▸ NFE2L2 Q16236 1/20 0.44
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599380 0.87 MEN1 (0.44) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599329 0.86 KMT2A (0.55) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599453 0.79 KEAP1 (0.46) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599324 0.76 MEN1 (0.47) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599368 0.73 KDM4E (0.48) KDM4EMEN1KMT2ALMNAMAPT
SCHEMBL17599358 0.73 ALDH1A1 (0.58) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599361 0.73 KDM4E (0.43) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599373 0.73 KMT2A (0.46) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599366 0.72 KDM4E (0.41) ALDH1A1KDM4EMEN1HPGDCRHBP
SCHEMBL17599409 0.72 MEN1 (0.38) ALDH1A1KDM4EMEN1HPGDCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback